These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29744846)

  • 1. Preparation of Stable Amyloid-β Oligomers Without Perturbative Methods.
    Kotler SA; Ramamoorthy A
    Methods Mol Biol; 2018; 1777():331-338. PubMed ID: 29744846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A discrete mathematical model for the aggregation of β-Amyloid.
    Dayeh MA; Livadiotis G; Elaydi S
    PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkali ion influence on structure and stability of fibrillar amyloid-β oligomers.
    Huraskin D; Horn AHC
    J Mol Model; 2019 Jan; 25(2):37. PubMed ID: 30637529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
    Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
    FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a Well-Defined and Stable β-Barrel Pore-Forming Aβ42 Oligomer.
    Serra-Batiste M; Ninot-Pedrosa M; Puig E; Ciudad S; Gairí M; Carulla N
    Methods Mol Biol; 2018; 1779():13-22. PubMed ID: 29886524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the aggregation mechanism of Aβ(25-40).
    Xiong J; JiJi RD
    Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-lived Aβ oligomer resistant to fibrillization.
    Nick M; Wu Y; Schmidt NW; Prusiner SB; Stöhr J; DeGrado WF
    Biopolymers; 2018 Aug; 109(8):e23096. PubMed ID: 29319162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and Use of Recombinant Aβ for Aggregation Studies.
    O'Malley TT; Linse S; Walsh DM
    Methods Mol Biol; 2018; 1777():307-320. PubMed ID: 29744844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing oligomerization of amyloid beta peptide in silico.
    Dorosh L; Stepanova M
    Mol Biosyst; 2016 Dec; 13(1):165-182. PubMed ID: 27844078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disaggregation of Aβ42 for Structural and Biochemical Studies.
    Chung H; Crooks EJ; Ziliox M; Smith SO
    Methods Mol Biol; 2018; 1777():321-330. PubMed ID: 29744845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
    Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
    Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemically engineered, stable oligomer mimic of amyloid β42 containing an oxime switch for fibril formation.
    Yamamoto M; Shinoda K; Ni J; Sasaki D; Kanai M; Sohma Y
    Org Biomol Chem; 2018 Sep; 16(35):6537-6542. PubMed ID: 30167602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation States of A
    Festa G; Mallamace F; Sancesario GM; Corsaro C; Mallamace D; Fazio E; Arcidiacono L; Garcia Sakai V; Senesi R; Preziosi E; Sancesario G; Andreani C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Investigation of Crucial Oligomers in the Early Stages of Aβ40 and Aβ42 Aggregation.
    Morel B; Conejero-Lara F
    Methods Mol Biol; 2023; 2551():15-28. PubMed ID: 36310193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of neurotoxic tau oligomers.
    Lasagna-Reeves CA; Castillo-Carranza DL; Guerrero-Muoz MJ; Jackson GR; Kayed R
    Biochemistry; 2010 Nov; 49(47):10039-41. PubMed ID: 21047142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
    Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
    Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.
    Sahoo BR; Cox SJ; Ramamoorthy A
    Chem Commun (Camb); 2020 Apr; 56(34):4627-4639. PubMed ID: 32300761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.